Literature DB >> 26353029

Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox.

David J Dowling1, Ofer Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26353029      PMCID： PMC4931280          DOI： 10.1097/INF.0000000000000893

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  24 in total

Review 1.  Systematic identification of small molecule adjuvants.

Authors:  Darren R Flower
Journal:  Expert Opin Drug Discov       Date:  2012-06-24       Impact factor: 6.098

Review 2.  Vaccine adjuvant formulations: a pharmaceutical perspective.

Authors:  Luis A Brito; Padma Malyala; Derek T O'Hagan
Journal:  Semin Immunol       Date:  2013-07-12       Impact factor: 11.130

3.  Predictive markers of safety and immunogenicity of adjuvanted vaccines.

Authors:  Beatris Mastelic; Nathalie Garçon; Giuseppe Del Giudice; Hana Golding; Marion Gruber; Pieter Neels; Bernard Fritzell
Journal:  Biologicals       Date:  2013-09-23       Impact factor: 1.856

Review 4.  Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors:  Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal:  Hum Vaccin Immunother       Date:  2013-12-03       Impact factor: 3.452

Review 5.  Beyond empiricism: informing vaccine development through innate immunity research.

Authors:  Stuart M Levitz; Douglas T Golenbock
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 6.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 7.  Preclinical evaluation of MenB vaccines: prerequisites for clinical development.

Authors:  Holly Sanders; Patricia Kaaijk; Germie Pjm van den Dobbelsteen
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

8.  A 2020 vision for vaccines against HIV, tuberculosis and malaria.

Authors:  Rino Rappuoli; Alan Aderem
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

Review 9.  Accelerating next-generation vaccine development for global disease prevention.

Authors:  Wayne C Koff; Dennis R Burton; Philip R Johnson; Bruce D Walker; Charles R King; Gary J Nabel; Rafi Ahmed; Maharaj K Bhan; Stanley A Plotkin
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

Review 10.  Vaccines for the twenty-first century society.

Authors:  Rino Rappuoli; Christian W Mandl; Steven Black; Ennio De Gregorio
Journal:  Nat Rev Immunol       Date:  2011-11-04       Impact factor: 53.106
View more
  22 in total

1.  Vaccine adjuvants: Softness makes it better.

Authors:  Herman F Staats; David J Burkhart
Journal:  Nat Mater       Date:  2018-01-23       Impact factor: 43.841

2.  Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery.

Authors:  Brittany A Moser; Rachel C Steinhardt; Aaron P Esser-Kahn
Journal:  ACS Biomater Sci Eng       Date:  2016-12-01

3.  TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.

Authors:  David J Dowling; Simon D van Haren; Annette Scheid; Ilana Bergelson; Dhohyung Kim; Christy J Mancuso; Willemina Foppen; Al Ozonoff; Lynn Fresh; Terese B Theriot; Andrew A Lackner; Raina N Fichorova; Dmitri Smirnov; John P Vasilakos; Joe M Beaurline; Mark A Tomai; Cecily C Midkiff; Xavier Alvarez; James L Blanchard; Margaret H Gilbert; Pyone Pyone Aye; Ofer Levy
Journal:  JCI Insight       Date:  2017-03-23

4.  Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.

Authors:  David J Dowling; Soumik Barman; Alyson J Smith; Francesco Borriello; Danielle Chaney; Spencer E Brightman; Gandolina Melhem; Byron Brook; Manisha Menon; Dheeraj Soni; Simone Schüller; Karthik Siram; Etsuro Nanishi; Hélène G Bazin; David J Burkhart; Ofer Levy; Jay T Evans
Journal:  Sci Rep       Date:  2022-10-18       Impact factor: 4.996

5.  A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity.

Authors:  David J Dowling; Holly Sanders; Wing Ki Cheng; Sweta Joshi; Spencer Brightman; Ilana Bergelson; Carlo Pietrasanta; Simon D van Haren; Sandra van Amsterdam; Jeffrey Fernandez; Germie P J M van den Dobbelsteen; Ofer Levy
Journal:  Front Immunol       Date:  2016-12-08       Impact factor: 7.561

6.  Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.

Authors:  David J Dowling; Evan A Scott; Annette Scheid; Ilana Bergelson; Sweta Joshi; Carlo Pietrasanta; Spencer Brightman; Guzman Sanchez-Schmitz; Simon D Van Haren; Jana Ninković; Dina Kats; Cristiana Guiducci; Alexandre de Titta; Daniel K Bonner; Sachiko Hirosue; Melody A Swartz; Jeffrey A Hubbell; Ofer Levy
Journal:  J Allergy Clin Immunol       Date:  2017-03-23       Impact factor: 10.793

7.  Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization.

Authors:  Francesco Borriello; Carlo Pietrasanta; Jacqueline C Y Lai; Lois M Walsh; Pankaj Sharma; David N O'Driscoll; Juan Ramirez; Spencer Brightman; Lorenza Pugni; Fabio Mosca; David J Burkhart; David J Dowling; Ofer Levy
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

Review 8.  First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines.

Authors:  Francesco Borriello; Simon D van Haren; Ofer Levy
Journal:  mSphere       Date:  2018-08-01       Impact factor: 4.389

9.  Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.

Authors:  Djin-Ye Oh; David J Dowling; Saima Ahmed; Hyungwon Choi; Spencer Brightman; Ilana Bergelson; Sebastian T Berger; John F Sauld; Matthew Pettengill; Alvin T Kho; Henry J Pollack; Hanno Steen; Ofer Levy
Journal:  Mol Cell Proteomics       Date:  2016-03-01       Impact factor: 5.911

10.  Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn.

Authors:  Annette Scheid; Francesco Borriello; Carlo Pietrasanta; Helen Christou; Joann Diray-Arce; Matthew A Pettengill; Sweta Joshi; Ning Li; Ilana Bergelson; Tobias Kollmann; David J Dowling; Ofer Levy
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.